Pyrrolidine-based cationic γ-peptide: a DNA-binding molecule works as a potent anti-gene agent
Pyrrolidine-based cationic peptides showing high stability to enzyme degradation and strong binding affinity towards DNA are widely investigated as tools to interfere in gene expression. Several studies have been focused on γ-peptide analogs with modifications on the peptide backbone in the attempt...
Gespeichert in:
Veröffentlicht in: | Medicinal chemistry research 2022-03, Vol.31 (3), p.507-516 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Pyrrolidine-based cationic peptides showing high stability to enzyme degradation and strong binding affinity towards DNA are widely investigated as tools to interfere in gene expression. Several studies have been focused on γ-peptide analogs with modifications on the peptide backbone in the attempt to overcome solubility, uptake, and aggregation issues. Pyrrolidine-based γ-peptide derivatives having two different modes of backbone conformation show interesting properties in terms of secondary structure and affinity of binding towards nucleic acids. In this paper, we illustrate our results obtained on two cationic 8-mer γ-peptides
Gp1
and
Gp2
, and how they differ in side-chain spacing along the backbone was tested for DNA binding and DNA transfection activity. Both γ-peptides are stable toward protease digestion.
Gp1
binds to DNA more tightly than
GP2
. This binding ability of
Gp1
is attributed to its characteristic of single-chain PPII-like conformation. The
Gp1
shows a reduction in its electrophoretic mobility when treated with plasmid DNA. The DNA transfection ability of γ-peptide
Gp1
was compared with commercially available transfection reagent Effectene. In each case,
Gp1
significantly enhanced the transfection efficiency (40%) of plasmid in Schneider cells compared to the commercial reagent (18%). The other γ-peptide
GP2
is not active. |
---|---|
ISSN: | 1054-2523 1554-8120 |
DOI: | 10.1007/s00044-021-02833-3 |